Global /Taiwan /Healthcare /Drug Manufacturers - Specialty & Generic /7595
chevron_leftBack
Pharmigene, Inc. logo

Pharmigene, Inc.

7595
TPEX: 7595 Delayed
10.00TWD 0%
0.3169 USD
As of 9 June 2026, Pharmigene, Inc. has a market cap of $15.98M USD, ranking #38570 globally and #2279 in Taiwan. It ranks #3440 in the Healthcare sector, and #223 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
38570
Country Rank
2279
Sector Rank
3440
Industry Rank
223
Key Stats
Market Cap
$15.98MUSD
504.65M TWD
Enterprise Value
$33.16MUSD
1.05B TWD
Revenue (TTM)
$4.73MUSD
149.25M TWD
EBITDA (TTM)
-$1.46MUSD
-46.2M TWD
Net Income (TTM)
-$2.39MUSD
-75.51M TWD
EBITDA Margin
-31%
Profit Margin
-51%
PS Ratio
3.4
PB Ratio
1.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Fuhui Zhan open_in_new
Founded
1994
Website
pharmigene.com.tw open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0% -4.8% -4.8% -9.5% -1% -19%

News

Loading...

Markets

Exchange Ticker Price
Taipei Exchange
MIC: ROCO
PRIMARY
7595
世基生物醫學股份有限公司 Ordinary Shares
ISIN: TW0007595B13
Shares Out.:
50.465M1
TV:
SA:
YF:
GF:
BA:
MS:
10.00 TWD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Pharmigene, Inc.

Pharmigene, Inc. designs, develops, manufactures, and sells diagnostic tests in Taiwan and internationally. It offers molecular diagnostics to test adverse drug reactions; and DNA extraction products for gene expression analysis, clinical molecular diagnosis, human identity testing, forensics, and biomedical research applications. The company also provides pharmacogenomics test, drug allergy test, and functional medicine test services. In addition, it distributes various genomics and genetics equipment and reagents; and provides professional consultation, training program, analysis software, and technical support solutions. Further, the company offers CDMO services. The company was founded in 1994 and is headquartered in Taipei, Taiwan.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (Taiwan)
Name
Market Cap diff.
PE
$1.68B
52.95B TWD
10K%
17.9
1707
$534.8M
16.89B TWD
3K%
14.0
$474.56M
14.99B TWD
3K%
36.5
8436
$413.48M
13.06B TWD
2K%
13.7
4128
$290.57M
9.18B TWD
2K%
-
7832
$243.37M
7.69B TWD
1K%
-
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
$37.17B
108.92B ILS
232K%
24.2
$29.56B
185K%
-
$15.84B
107.34B CNY
99K%
16.0
CIPLA
$11.16B
1.06T INR
70K%
23.4
LUPIN
$11.04B
1.05T INR
69K%
22.7
$9.09B
61.6B CNY
57K%
80.6
chevron_leftBack